Literature DB >> 22726459

Comparative proteomic profiles indicating genetic factors may involve in hepatocellular carcinoma familial aggregation.

Da-Ni Zhong1, Qiu-Yue Ning, Ji-Zhou Wu, Ning Zang, Jian-Lin Wu, Die-Fei Hu, Shuang-Yan Luo, Ai-Chun Huang, Lan-Lan Li, Guo-Jian Li.   

Abstract

Familial aggregation of hepatocellular carcinoma (HCC), the third leading cause of cancer death worldwide, has shown to be a common phenomenon. We investigated the association between the genetic background and HCC familial aggregation. Serum samples were collected from HCC family members and normal control family members for screening the differentially expressed protein peaks with the approach of surface-enhanced laser desorption ionization time-of-flight mass spectrometry. Potential genetically associated protein peaks were selected and further identified by matrix assisted laser desorption ionization-time of flight mass spectrometry. A panel of six protein peaks (m/z 6432.94, 8478.35, 9381.91, 17284.67, 17418.34, and 18111.04) were speculated to reflect the genetic susceptibility of HCC familial aggregation. Three of them (m/z 6432.94, 8478.35, and 9381.91) were selected to identify as the candidate proteins. Nine identified proteins, including mostly apolipoprotein family (ApoA1, ApoA2, ApoC3, ApoE) and serum amyloid A protein (SAA), were found overexpressed in the multiple HCC cases family members. The comparative proteomic profiles have suggested that genetic factors ought to be taken into account for familial aggregation of HCC.
© 2012 Japanese Cancer Association.

Entities:  

Mesh:

Year:  2012        PMID: 22726459     DOI: 10.1111/j.1349-7006.2012.02368.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  9 in total

1.  Human liver tissue metabolic profiling research on hepatitis B virus-related hepatocellular carcinoma.

Authors:  Shu-Ye Liu; Rikki-Lei Zhang; Hua Kang; Zhi-Juan Fan; Zhi Du
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

2.  Gene expression profiling of MYC-driven tumor signatures in porcine liver stem cells by transcriptome sequencing.

Authors:  Rajagopal N Aravalli; Neil C Talbot; Clifford J Steer
Journal:  World J Gastroenterol       Date:  2015-02-21       Impact factor: 5.742

3.  Familial Hepatocellular Carcinoma- First Reported Case from India.

Authors:  Smita Chandra; Anuradha Kusum; Harish Chandra; Kanika Yadav; Sanjiv Kumar Verma
Journal:  J Clin Diagn Res       Date:  2016-03-01

4.  Association of VEGFA polymorphisms with susceptibility and clinical outcome of hepatocellular carcinoma in a Chinese Han population.

Authors:  Fei Liu; Limei Luo; Yonggang Wei; Wentao Wang; Tianfu Wen; Jiayin Yang; Mingqing Xu; Bo Li
Journal:  Oncotarget       Date:  2017-03-07

5.  Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.

Authors:  Tao Zhang; Jianrong Guo; Jian Gu; Zheng Wang; Guobin Wang; Huili Li; Jiliang Wang
Journal:  Oncol Rep       Date:  2018-11-01       Impact factor: 3.906

6.  Identification of CD14 as a potential biomarker of hepatocellular carcinoma using iTRAQ quantitative proteomics.

Authors:  Jiao Guo; Rui Jing; Jian-Hong Zhong; Xin Dong; Yun-Xi Li; Yin-Kun Liu; Tian-Ren Huang; Chun-Yan Zhang
Journal:  Oncotarget       Date:  2017-06-28

Review 7.  Familial hepatocellular carcinoma: 'A model for studying preventive and therapeutic measures'.

Authors:  Elroy Patrick Weledji
Journal:  Ann Med Surg (Lond)       Date:  2018-09-28

8.  Identification of key pathways and biomarkers in sorafenib-resistant hepatocellular carcinoma using bioinformatics analysis.

Authors:  Danping Huang; Weiqu Yuan; Hanmin Li; Shaodong Li; Zuanguang Chen; Hongzhi Yang
Journal:  Exp Ther Med       Date:  2018-07-09       Impact factor: 2.447

9.  Tracking the important role of JUNB in hepatocellular carcinoma by single-cell sequencing analysis.

Authors:  Peng Yan; Bin Zhou; Yingdong Ma; Ani Wang; Xiaojun Hu; Youli Luo; Yajun Yuan; Yajun Wei; Pengfei Pang; Junjie Mao
Journal:  Oncol Lett       Date:  2019-12-20       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.